Founded after a decade of research by Paula Jagemann, Fortitude BioCuisine was built at the intersection of systems thinking, operational execution, and clinically disciplined nutrition. Paula brings a wealth of experience from transformative technology ventures, including her role in UUNET’s rise as an internet backbone leader and her founding of ECI Solutions, which secured $92 million in venture capital and was sold to The Carlyle Group for approximately $500 million. For the past decade, she has dedicated herself exclusively to developing Fortitude BioCuisine — a measurable nutrition and continuity-of-care architecture designed for clinically vulnerable patients.

Fortitude BioCuisine addresses cancer cachexia, a critical condition present in 80% of patients undergoing cancer treatment, with approximately 33% perishing from this known side effect of invasive drug treatments such as chemotherapy and radiation. Our controlled-input culinary methodology, ingredient integrity frameworks, and supportive-care nutrition systems are designed for patients facing cachexia, frailty, survivorship challenges, and metabolic stress. We position ourselves not as a traditional food company, but as a disciplined nutrition and continuity-of-care architecture built around operational standards and real-world implementation.